Omnitram Safety and Efficacy in the Treatment of Diabetic Neuropathy

NCT03664921 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

55

Enrollment

INDUSTRY

Sponsor class

Conditions

Diabetic Neuropathies
Neuropathic Pain
Pain, Chronic

Interventions

DRUG: Omnitram Oral Tablet
DRUG: Placebo Oral Tablet

Sponsor

Syntrix Biosystems, Inc.

Collaborators

[object Object]
[object Object]